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Abstract
Introduction: Non-enzymatic glycation of proteins has been
implicated in various diabetic complications and age-related
disorders. Proteins undergo glycation at the N-terminus or at
the O-amino group of lysine residues. The observation that only a
fraction of all lysine residues undergo glycation indicates the role
of the immediate chemical environment in the glycation reaction.
Here we have constructed helical peptide models, which juxtapose
lysine with potentially catalytic residues in order to probe their
roles in the individual steps of the glycation reaction.
Results : The peptides investigated in this study are constrained
to adopt helical conformations allowing residues in the i and i+4
positions to come into spatial proximity, while residues i and i+2
are far apart. The placing of aspartic acid and histidine residues at
interacting positions with lysine modulates the steps involved in
early peptide glycation (reversible Schiff base formation and its
subsequent irreversible conversion to a ketoamine product, the
Amadori rearrangement). Proximal positioning of aspartic acid or
histidine with respect to the reactive lysine residue retards initial
Schiff base formation. On the contrary, aspartic acid promotes
catalysis of the Amadori rearrangement. Presence of the strongly
basic residue arginine proximate to lysine favorably affects the
pKa of both the lysine O-amino group and the singly glycated
lysine, aiding in the formation of doubly glycated species. The
Amadori product also formed carboxymethyl lysine, an advanced
glycation endproduct (AGE), in a time-dependent manner.
Conclusions: Stereochemically defined peptide scaffolds are
convenient tools for studying near neighbor effects on the
reactivity of functional amino acid sidechains. The present study
utilizes stereochemically defined peptide helices to effectively
demonstrate that aspartic acid is an efficient catalytic residue in
the Amadori arrangement. The results emphasize the structural
determinants of Schiff base and Amadori product formation in the
final accumulation of glycated peptides. ß 2001 Elsevier Science
Ltd. All rights reserved.
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1. Introduction
Non-enzymatic glycation of proteins has been impli-
cated as an important cause of the complications associ-
ated with diabetes [1^4]. The Maillard hypothesis suggests
that chemical modi¢cation of proteins by glucose and sub-
sequent reactions of the adduct may result in products
which are directly responsible for many pathological con-
ditions in diabetes [1,5,6]. The reaction of glucose with
amino groups in proteins results in the reversible forma-
tion of a Schi¡ base or aldimine, which can undergo irre-
versible Amadori rearrangement (Fig. 1) to form a keto-
amine product. Glycation is also a process that appears to
be associated with age-related disorders and may be par-
ticularly important in the context of long-lived proteins
which do not undergo rapid synthesis and turnover [3,
7^14].
The initial observation that hemoglobin was glycated in
vivo [15,16], speci¢cally at the N-terminus of the L-chain
(Val1L), triggered o¡ a very large number of investigations
on the non-enzymatic glycation of proteins in vivo and in
vitro. The purpose of many such studies was the charac-
terization of site-speci¢city of glycation and the factors
catalyzing rearrangement to the Amadori product. While
hemoglobin has inevitably been the focus of the majority
of mechanistic investigations [17^21], the glycation of a
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variety of other proteins, notably albumin [22,23], K- and
L-crystallins [24], collagen [25], RNase A [26,27], human
and horse liver alcohol dehydrogenase [28], Cu^Zn-super-
oxide dismutase [29] and various erythrocytic proteins [29^
32], has also been studied.
Non-enzymatic glycation of proteins involves modi¢ca-
tion of, primarily, the O-amino group of lysine and the free
N-terminus. But, only a small proportion of all lysyl res-
idues undergoes glycation. It has been suggested that the
immediate chemical environment of an amino group mod-
ulates the glycation reaction. Factors a¡ecting the pKa of
the amino group would be instrumental in determining the
rate of formation of Schi¡ base adducts, while the prox-
imity of groups capable of proton abstraction augments
the e⁄ciency of the rearrangement reaction, to form the
ketoamine product. Proposed sites of preferential Schi¡
base formation are stretches of lysyl residues [19] (e.g.
The principle glycation site of albumin, Lys525, lies in a
Lys^Lys sequence [22,23]) and the N-terminus of proteins
characterized by its low pKa (e.g. NK-Lys1 in RNase A
[26]). Factors suggested to in£uence the Amadori rear-
rangement are imidazole groups of histidine residues
[23,28], carboxylate groups of acidic residues [19,26] and
bound phosphate ions and other negatively charged ions
[26,33]. The role of some proposed amino acid catalysts
has been studied in model di- and tri-peptides and the
presence of histidine was shown to accelerate the glycation
reaction [34,35].
The purpose of the present study is to examine the role
of spatially proximate residues on the formation of the
aldimine and its subsequent rearrangement to the Ama-
dori product. Towards this end, we have designed a series
of helical peptides containing a single, centrally positioned
lysyl residue to serve as a glycation site. In two of the
sequences listed in Fig. 2, we have chosen to vary the
relative positioning of a potential catalytic residue for
the Amadori reaction, aspartic acid (KD4/KD2). In pep-
tide KH4, the aspartyl residue of peptide KD4 has been
replaced by the basic histidine residue, while peptide
RKD4 has both acidic (aspartic acid) and basic (arginine)
residues £anking the lysine. The choice of sequences was
based on the fact that in peptide helices, residues i and i+4
lie on the same face of the helix, while residues i and i+2
are spatially far apart (Fig. 3). Helical conformations in
the designed peptides were nucleated and stabilized by
introduction of the K,K-dialkyl residue (K-aminoisobutyric
acid, Aib, U) at four positions. The ability of Aib residues
to stabilize helical conformations in oligopeptides has been
extensively demonstrated by crystallographic studies [36^
40]. Spectroscopic studies in solution establish that pep-
Fig. 1. Schematic representation of the reactions involved in the glycation of proteins. The open chain form of the sugar (glucose) reacts with the O-ami-
no group of lysine residues to form a Schi¡ base, which undergoes the Amadori rearrangement to form a ketoamine product. This ketoamine is subject
to a series of reactions which result in AGEs, one of which is CML.
               
               
               
               
     
               
Fig. 2. Sequences of synthetic peptides used as glycation models. The
potential glycation site (Lys6) is in purple, while acidic (Asp10) and ba-
sic residues (His10/Arg3) are in red and blue, respectively.
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tides of length less than 20 residues which contain three or
four Aib residues, adopt largely helical conformations
[41,42]. In the present study, the incorporation of four
Aib residues in a 15 residue sequence is anticipated to
result in the formation of a relatively well-de¢ned helical
sca¡old upon which the functional side chains are arrayed.
The peptide termini were chemically blocked with an ace-
tyl group at the N-terminus and a carboxamide moiety at
the C-terminus. This allows for an additional hydrogen
bond to be formed at each end of the helix, reducing the
number of unsatis¢ed NH and CO groups [43]. A peptide,
K14, which contained only the reactive site lysine with no
prospective catalytic residues in close proximity, served as
a control for evaluating neighboring group e¡ects. This
peptide was accidentally obtained as a deletion product
during the synthesis of peptide KH4 (His10 deleted).
The results described in this paper establish that the prox-
imal carboxylate of Asp serves as the internal catalyst of
the Amadori rearrangement in the designed peptides KD4
and RKD4.
2. Results
2.1. Circular dichroism of peptides
The far UV CD spectra of all ¢ve peptides (Fig. 4) in
methanol resemble classical helical patterns with negative
bands at 208 nm and between 220 and 222 nm [44,45].
Values of molar ellipticity at 222 nm, which is considered
an index of helix content, either exceeded (peptide KH4)
or were comparable (peptides RKD4 and KD2) to those
observed for model alanine-based peptides studied by
Baldwin and co-workers [46]. The presence of a tyrosine
residue (which contributes to the CD signal at 222 nm
[47]) precludes accurate estimation of helix content. Fur-
thermore, in constrained peptides where helicity has been
induced by introduction of folding nuclei, observed ellip-
ticities greatly exceed that anticipated for ‘100% helix’
based on earlier models [48]. However, the amino acid
composition of all ¢ve peptides is very similar, as is
the length, and hence relative helicities can be compared.
Fig. 3. Spatial juxtaposition of Lys6 (the glycation site) and the catalytic aspartic acid in a peptide helix, viewed perpendicular to (top panel) and down
(bottom panel) the helix axis. Lys6 and Asp10 are proximate in KD4, while Lys6 and Asp8 are far apart in KD2. In RKD4, Arg3 and Asp10 lie on
the same helix face as Lys6.
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Peptide K14 is shorter by a residue, but this is not ex-
pected to have a signi¢cant in£uence on the intrinsic hel-
icity.
The extent of helicity follows the order KH4sK14s
KD4sKD2sRKD4. In all cases, there is a small reduc-
tion in helicity in 50% methanol/water mixtures, which is
expected in view of the tendency of water to compete
for backbone hydrogen-bonding sites. Peptide KH4 and
KD4, characterized by the most intense CD bands, are
the most structured, perhaps due to structure-stabilizing
interactions between residues Lys6 and Asp10 (in KD4)
or the deprotonated form of His10 (in KH4), while the
CD spectrum of the dibasic RKD4 suggests that it is
least helical. In all cases, the CD data suggest that a sub-
stantial fraction of peptide molecules in solution adopt
folded helical structures, permitting further discussion of
reactions to be based on the assumption of a helical scaf-
fold.
2.2. Mass spectrometry (MS) of peptides and glycated
peptides
MS is a convenient technique for monitoring reactions
involving changes in reactant masses. Both matrix-assisted
laser desorption ionization (MALDI) and electrospray
ionization (ESI)-MS have been utilized for the qualitative
as well as quantitative measurement of glycated proteins
and peptides [49,50] and the characterization of the ad-
vanced glycation products in the Maillard reaction [51^
59]. ESI-MS has therefore been utilized in this investiga-
tion to monitor the rate of glycation of the designed pep-
tides and to identify the various reaction intermediates.
The progress of the glycation reaction can be detected
using MS as an increase in mass over that of the peptide
under investigation. The change in mass corresponds to
the addition of a glucose moiety with the concomitant
loss of a water molecule (vMr = 162). All ¢ve peptides
Fig. 4. CD spectra of peptides KD4 (red), KD2 (green), KH4 (blue), K14 (pink) and RKD (yellow) in 100% methanol (a) and 50% water/methanol
mixtures (O).
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Fig. 5. ESI mass spectra of peptide KD4 (a) showing various charge states observed, (b) 44 h into the glycation reaction (the spectrum shows charge
states corresponding to both peptide (e.g. [P+2H]2) and glycated peptide (e.g. [Pg+2H]2), see Table 1 for full listing of all charge states observed) and
(c) 44 h into the glycation reaction after treatment with hydroxylamine. This glycated species corresponds to the fraction of all glycated KD4 that has
undergone the Amadori rearrangement and is hence the ketoamine product.
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used in the present investigation (KD4/KD2/KH4/RKD4/
K14) have two or three basic residues and hence the ca-
pacity to pick up multiple protons to form higher charged
species. The peptide KD4 has the potential to acquire two
protons, one each on the basic lysine and arginine resi-
dues. The observation of triply charged ions in KD4 (Fig.
5a) is rationalized by the ability of peptide helices to be
protonated at the C-terminus, where between two and
three free backbone carbonyl groups are available. Nota-
bly, in a helical conformation, the negatively charged end
of the helix macrodipole is placed at the C-terminus, facil-
itating protonation and metallation even in neutral, apolar
helical peptides, under electrospray conditions (unpub-
lished results). In addition, the carboxyl groups of the
residues aspartic acid and glutamic acid can form sodium
adducts. The MS analysis of such a heterogeneous mixture
reveals multiple peaks corresponding to the various pro-
ton/sodium adducts with appropriate m/z values. Fig. 5a,
the mass spectrum of peptide KD4, shows the presence of
a doubly protonated species ([P+2H]2, m/z 780.5), a dou-
bly charged sodium adduct ([P+Na3H+2H]2, m/z 791.5),
a triply protonated species ([P+3H]3, m/z 521.0) and a
triply charged sodium adduct ([P+Na3H+3H]3, m/z
528.5). Fig. 5b, the mass spectrum of KD4 recorded
44 h into the glycation reaction, shows many such multi-
ply charged adducts for both the intact peptide as well
as its glycated form. Table 1 lists the charged species
observed for the free and glycated forms of all ¢ve pep-
tides.
2.3. Glycation of peptides KD4, KD2, KH4 and K14
Peptide glycation was investigated under di¡erent con-
ditions of pH (pH 6.5, 7.5 and 8.5) and temperature (room
temperature and 37‡C) for peptides KD4 and KD2. No
glycation was observed at pH 6.5 for both peptides. At
room temperature, glycation was faster at pH 8.5 than at
pH 7.5. On the contrary, at 37‡C, glycation rates were
comparable for both conditions of pH. This similarity in
the glycation rates at pH 7.5 and 8.5 at 37‡C was observed
for peptides K14 and KH4 as well. Hence, all data con-
sidered for discussion in this report were acquired at pH
8.5 and 37‡C.
The lysine residue of each peptide formed adducts with
glucose under the experimental conditions studied. Figs.
5b, 6a, 7a and 8a are representative spectra for the glyc-
ation of KD4, KD2, KH4 and RKD4, respectively. The
glycated species observed in these spectra include both
aldimine and ketoamine forms, which are isomeric and
hence indistinguishable by ESI and MS under conditions
where only multiply charged molecular ions are detected.
Fig. 9 depicts the glycation reaction of KD4, KD2, KH4
and K14 as a function of time (The di¡erences in the time
scales for the two groups of peptides, KD4/KD2 and
KH4/K14, are because of widely di¡erent rates of glyc-
ation and subsequent reactions). The relative intensities
of the peaks corresponding to glycated and intact peptides
in the mass spectra were used as an index of the glycation
reaction. Complex reaction pro¢les are observed in all
Table 1
Charge states observed for peptides KD4, KD2, KH4 and RKD4 and their various glycated forms
Peptide Charged species observed m/z (Da)
Peptide (P) Peptide+glucose (Pg) Peptide+2glucose
KD4 [M+2H]2 780.5 861.6
Mcalc = 1559.6 Da [M+Na3H+2H]2 791.5 872.7
[M+2Na32H+2H]2 802.5 883.7
[M+3Na33H+2H]2 813.6 894.6
[M+3H]3 520.8 575.0
[M+Na3H+3H]3 528.3 582.3
KD2 [M+2H]2 780.6 861.8
Mcalc = 1559.6 Da [M+Na3H+2H]2 791.7 872.8
[M+2Na32H+2H]2 802.6 883.7
[M+3Na33H+2H]2 813.6 894.6
[M+3H]3 520.8 574.8
[M+Na3H+3H]3 528.2 582.0
KH4 [M+2H]2 791.5 872.7
Mcalc = 1581.6 Da [M+Na3H+2H]2 802.5 883.6
[M+2Na32H+2H]2 813.5 894.5
[M+3H]3 528.4 582.2
KH4-CML Mcalc = 1639.6 Da [M+2H]2 820.5
RKD2 [M+2H]2 780.5 861.5 943.3
Mcalc = 1559.6 Da [M+Na3H+2H]2 791.5 872.5 954.3
[M+2Na32H+2H]2 802.5 883.5
[M+3Na33H+2H]2 813.5 894.5
[M+3H]3 520.8 574.8 628.9
[M+Na3H+3H]3 528.0 582.2 636.2
[M+2Na32H+3H]3 535.3 589.5
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four peptides. In all four cases, the glycation reaction ap-
pears to pass through distinct stages. Initial appearance of
the glucose adduct is very rapid with near linear reaction
kinetics. The reaction then brie£y saturates, followed by a
decrease in total glycation. Amounts of glycated peptide
then increase again and soon saturate. While the reaction
pro¢le of glycation is similar for the four peptides, e⁄-
ciency of glycation varies in terms of maximum glycation
observed, time taken for the reaction to reach saturation
and the magnitude of the decrease interrupting saturation.
Maximum glycation is observed in K14 (with 76% of total
peptide being glycated at 3 h), followed by KH4 (62% at
6 h) and KD2 (60% at 23 h), while KD4 showed least total
glycation (44% at saturation). Peptide KD4 was also the
¢rst to attain saturation and showed the least decrease in
glycation amounts. This dip was most prominent in K14,
with the subsequent rise also being low.
2.4. Amadori product formation in peptides KD4, KD2,
KH4 and K14
In order to probe the rates of Amadori product forma-
tion, it is important to accurately di¡erentiate between the
aldimine and ketoamine forms of the glycated peptides.
The lability of the aldimine linkage, and consequent rever-
sal of Schi¡ base formation, has been well documented.
Studies on the formation of Schi¡ base adducts between
hemoglobin and aliphatic and aromatic aldehydes [60] re-
Fig. 6. ESI mass spectra of peptide KD2 (a) 44 h into the glycation reaction (the spectrum shows charge states corresponding to both peptide (e.g.
[P+2H]2) and glycated peptide (e.g. [Pg+2H]2)) and (b) 44 h into the glycation reaction after treatment with hydroxylamine. Here too, the peaks in
the mass spectrum correspond to the ketoamine product. Comparison of (b) with Fig. 5c reveals less ketoamine formation in the case of KD2 than
KD4.
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veal that such linkages are susceptible to dialysis against
aldehyde free bu¡ers. Isbell and Frush [61] showed that
glycosylamines are hydrolyzed in weakly acidic solutions,
with maximum hydrolysis observed near pH 5.0. In addi-
tion, trans Schi¡ base reactions are observed on treatment
with hydrazine derivatives such as phenylhydrazine
[62,63], with release of the free amine. This reaction is
used in the displacement of pyridoxal phosphate from
Fig. 7. ESI mass spectra of peptide KH4 (a) 48 h into the glycation reaction, showing charge states corresponding to both peptide (e.g. [P+2H]2) and
glycated peptide (e.g. [Pg+2H]2) and (b) 48 h into the glycation reaction after treatment with hydroxylamine, showing peaks corresponding to the keto-
amine product. Comparison of (b) with Fig. 5c reveals less ketoamine formation in KH4 than KD4. Also seen in both spectra is a peak at m/z 820.5
which corresponds to the doubly charged carboxymethylated derivative of the peptide (CML).
C
Fig. 8. ESI mass spectra of peptide RKD4 (a) 24 h into the glycation reaction, (b) 24 h into the glycation reaction after treatment with hydroxylamine
and (c) 126 h into the glycation reaction. Comparison of (b) with Fig. 5c reveals equivalent amounts of ketoamine formation in peptide RKD4 as com-
pared to KD4. (c) Shows peaks corresponding to the doubly glycated form of peptide RKD4. Also seen in (b) and (c) are peaks at m/z 515.5 and
569.5 which correspond to dehydrated RKD4 and glycated RKD4, respectively. The amidated C-terminus of peptide RKD4 could have undergone de-
hydration to yield the nitrile. The greater ability of the nitrile to get protonated as compared to the amidated C-terminus of the peptide could be re-
£ected in the observation that only the triply charged species is observed in mass spectra.
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proteins bearing the coenzyme as a Schi¡ base [64]. Achar-
ya and Manning [65] have also used phenylhydrazine to
distinguish between aldimine and ketoamine forms of the
glyceraldehyde adducts of hemoglobin A. The relative la-
bility of the aldimine linkage in the presence of nucleo-
philic, hydrazine derivatives has been utilized to di¡eren-
tiate between the Schi¡ base and the Amadori product.
The reagent hydroxylamine, which rapidly causes release
of free amino groups from glucose^amine Schi¡ base ad-
ducts, has been used for this purpose in our studies.
Incubating the glycated peptide with hydroxylamine for
15 min caused complete conversion of the Schi¡ base ad-
duct to the unglycated peptide. MS analysis of the resul-
tant sample revealed estimates of Amadori product forma-
tion since the ketoamine is unreactive under these
conditions. It may be noted that, in principle, oxime for-
mation may be anticipated; but model experiments dem-
onstrated that this occurs only under forcing conditions.
The Amadori rearrangement product formed earliest in
the case of KD4 (Fig. 9a) with appearance of Amadori
product as early as 5 h. In addition, approximately twice
as much Amadori product was observed for KD4 (V30%
of total peptide amounts, or 66% of glycated peptide
amounts) as KD2 after 3 days. KH4 demonstrated a
greater potential to catalyze the Amadori reaction than
KD2, with Amadori product amounts equalling that of
KD4 when saturation was reached. However, the catalytic
e⁄ciency was lower, with KH4 requiring 7 days to pro-
duce ketoamine levels comparable to that of KD4. The
control peptide K14 demonstrated poor conversion poten-
tial with only 23% of total peptide bearing the Amadori
product even after 8 days.
2.5. The glycation reaction in peptide RKD4
While it was observed that aspartic acid catalyzed the
Amadori rearrangement reaction, rate of Schi¡ base for-
mation was poor in KD4 and appeared to be best under
conditions where no catalytic residue was present (peptide
K14). It could be argued that a strongly basic residue
proximate to the lysine residue might ameliorate the e¡ect
of aspartic acid and favorably a¡ect the pKa of Lys6,
resulting in rapid accumulation of aldimine adducts.
RKD4 would combine both features and have the basic
arginine residue and the catalytic aspartic acid residue
£anking the reactive site lysine. The initial glycation reac-
tion paralleled that of KH4 (45% of total peptide was
glycated at 9 h) and initial ketoamine formation was sim-
Fig. 9. Time course of the glycation reaction for peptides KD4, KD2,
KH4 and K14. (a) Compares the rate of total glycation and ketoamine
formation in peptides KD4 (b, R) and KD2 (a, O). Glycated peptide
amounts are represented as a percentage of total peptide amounts in the
reaction mixture (glycated+unglycated peptide). (b) Performs the same
comparison for peptides KH4 (b, R) and K14 (a, O).
Fig. 10. Time course of the glycation reaction for peptide RKD4. Total
glycation (b) is compared with formation of ketoamine and other prod-
ucts resistant to hydrolysis by hydroxylamine (a). Also indicated are
the approximate times of appearance of readily detectable amounts of
the ketoamine product, the bis-glucose adduct of lysine, the carboxy
methylated derivative of mono-glycated lysine and the ketoamine prod-
uct of the bis-glucose adduct.
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ilar to KD4 (KD4 caused Amadori rearrangement in
V29% of total glycated peptide at the end of 16 h when
RKD4 had catalyzed ketoamine formation in 28% of its
glycated component) (Figs. 8a,b and 10). RKD4 also
underwent a second glycation reaction (Fig. 8c) with the
product bearing two glucose moieties being detected in
spectra recorded after 30 h. This bis-glucose adduct, which
is a doubly glycated lysine (Fig. 11), also rearranged to
form the bis-ketoamine product, as distinguished using
hydroxylamine. Subsequently, glycation in terms of both
aldimine and ketoamine product formation continued, with
the reaction not attaining saturation even after 6 days,
when, V71% of the peptide was glycated, 23% of which
was in the doubly glycated form (16.2% of total peptide).
V82% of the glycated component had undergone the
Amadori rearrangement.
3. Discussion
Peptide models containing di¡erent catalytic residues
aid in the study of factors in£uencing Schi¡ base forma-
tion and Amadori rearrangement in the protein glycation
reaction. The use of helical sca¡olds permits positioning of
catalytic groups proximate to the glycation site. Compar-
ison of the glycation of KD4 with KD2, KH4 and K14
indicates that Schi¡ base formation in KD4 was the least
e⁄cient. The addition of glucose to the O-amino group of
the lysine residue to form a Schi¡ base is dependent on
deprotonation of the charged form of the amino group,
which is expected to predominate under the pH conditions
used in this study. The spatial proximity of Lys6 and
Asp10 in the helical conformation of KD4 might increase
the pKa of the lysine’s O-amino group, hindering deproto-
 
 
 
 
   
  
 
 
    
  
 
    
  
 
    
  
   
 
   
  
 
 
  
 
 
Fig. 11. Schematic representation summarizing the reactions occurring on the model peptide helices and the residues involved. The mechanism of Ama-
dori rearrangement on Lys6 is shown as catalyzed by Asp10. The proximity of the arginine residue and its e¡ect on the reactions involving Lys6 are
also highlighted. Peptide RKD4 contains all three residues, while KD4 contains only Lys6 and Asp10.
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nation and subsequent glycation. The slower initial glyc-
ation rate could a¡ect the overall rate of glycation of
KD4, resulting in lower product formation. Conversely,
the juxtaposition of Lys6 and Asp10 in KD4 catalyzes
the Amadori rearrangement reaction (Fig. 11), resulting
in increased amounts of glycated peptide which is resistant
to hydrolysis by hydroxylamine. The absence of such an
internal catalyst in KD2 results in a slower conversion
process despite rapid accumulation of the aldimine prod-
uct.
Histidine has often been implicated as a catalyst in
the glycation reaction because of its unique potential to
function as an acid^base catalyst near physiological pH
[28,34,35]. Unfortunately, in the in vitro experiments re-
ported here, glycation of the lysine residue is not observed
below pH 7.5. Under such conditions of pH, it is likely
that only the capacity of histidine to promote proton ab-
straction in the Amadori rearrangement may be moni-
tored. The diminished Schi¡ base formation seen in
KH4 as compared to K14 (which has no proximate func-
tional residues) seems to suggest that His10 exists in its
deprotonated state, and hence perhaps interacts with Lys6.
A comparison of peptides KH4 and KD4 suggests that
His10 also appears to catalyze the Amadori rearrangement
reaction, although less e⁄ciently than aspartic acid.
The positioning of a strongly basic residue such as ar-
ginine near Lys6 in peptide RKD4 appears to lower the
pKa of the lysine O-amino group, resulting in rapid forma-
tion of Schi¡ base adducts. This e¡ect of arginine extends
to the glucose^lysine adduct, aiding in the formation of a
doubly glycated species (Fig. 11). The double glycation of
lysine residues has been previously observed and charac-
terized using ESI-MS-MS in bovine K-crystallin, synthetic
peptides derived from the crystallin sequence and N-acetyl
lysine [66]. In the peptide RKD4, the second glycation on
Lys6 has been shown to undergo Amadori rearrangement
as well, presumably due to the proximity of the catalytic
Asp10. Hence, the ability of the immediate chemical envi-
ronment to in£uence both the pKa of the lysine residue
and the conversion of aldimine to ketoamine appears to be
important in dictating the course of the glycation reaction
at a potential reactive site.
No correlation is observed between the extent of glyc-
ation and the helical content of the peptides as detected by
CD. Indeed, peptide RKD4, which exhibits the lowest CD
ellipticities, appears to glycate most e⁄ciently. Further,
peptide KD2, which is similar to RKD4 in its CD char-
acteristics, glycates to a signi¢cantly less extent. Thus, sec-
ondary structural e¡ects on the glycation reaction appear
to be signi¢cant only in the context of the local chemical
environment provided to the glycation site.
The glycation reactions of all ¢ve peptides display a
curious dip in glycated peptide amounts after an initial
rapid phase of glycation. Examination of the state of glyc-
ation at this stage reveals that the glucose^lysine linkage is
in the aldimine form (as suggested by the hydroxylamine
reaction). The magnitude of the dip varied with the poten-
tial of the peptide to catalyze the Amadori rearrangement.
The dip is maximum in peptide K14, where the absence of
catalytic residues results in virtually no ketoamine product
over the time scale investigated. It has been suggested that
the aldimine undergoes a competing reaction to release
K-oxoaldehydes such as 3-deoxyglucosone, methyl glyoxal
and glyoxal [67]. The breakdown of the Schi¡ base to
glyoxal derivatives was proposed by Hayashi and Namiki
[68,69]. The observation of maximum loss of glycation in
K14, where indeed no subsequent rise in glycation levels
was seen, appears to suggest that such an alternative re-
action pathway predominates under conditions of poor
Amadori conversion of the Schi¡ base adduct (Fig. 1).
The formation of Schi¡ base adducts and Amadori
products have often been termed the early stages of the
glycation reaction. The Amadori product undergoes vari-
ous oxidation and cross-linking reactions (the late stages
of the Maillard reaction) to produce advanced glycation
endproducts (AGEs). Many such AGEs have been identi-
¢ed, the most commonly occurring being NO-carboxymeth-
yl lysine (CML) [70] and pentosidine [71] and their accu-
mulation has been implicated in a variety of age-related
disorders [2,9^14,72].
The appearance of a peak in MS experiments corre-
sponding to the mass of CML containing peptide was
also observed for peptides KD4, KH4, KD2 and RKD4
at various times. Despite the fact that identical experimen-
tal conditions were maintained for all peptides, attempts
to rationalize the time of appearance of CML with the
catalytic capacity of the peptides was unsuccessful, as
CML formation is modulated by a variety of potentially
oxidizing conditions [70] which were not controlled in the
present studies.
The results described in this report provide a clear dem-
onstration of neighboring group e¡ects in catalyzing glyc-
ation at lysine residues in peptides and subsequent irre-
versible Amadori rearrangement. The study highlights
the use of helical sca¡olds in dissecting proximity e¡ects
in catalysis and emphasizes the utility of ESI-MS as a
convenient technique for analyzing glycation reactions.
4. Signi¢cance
Both diabetes and ageing are associated with altered
glucose metabolism leading to high blood glucose levels,
which in turn increase the non-enzymatic glycation of di-
verse proteins. The reactions characterizing non-enzymatic
glycation have been the focus of many studies and the role
of neighboring residues or the immediate chemical envi-
ronment in accelerating these reactions has often been
emphasized.
We have attempted to combine the insights obtained
from studies on individual proteins in a peptide model,
which would provide a single potential glycation site
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(a lysine residue) with various chemical environments im-
plicated in the early steps of the glycation reaction. This
permits us to independently understand the factors in-
volved in initial Schi¡ base formation and subsequent
Amadori rearrangement in a protein-independent manner.
The study clearly demonstrates the role of factors a¡ecting
the pKa of amino groups in stimulating initial glycation
and the role of proximate bases in catalyzing the Amadori
rearrangement. The additive e¡ects of both features near a
potential glycation site, as seen in peptide RKD4, results
in accelerated accumulation of irreversibly glycated pep-
tide, which has the capacity to undergo further reactions
to form AGEs. The presence of such sites in proteins
would greatly aid AGE formation and accumulation, lead-
ing to associated disease complications.
Construction of peptide models, which can be easily
studied using ESI-MS, permits detailed understanding of
the mechanisms underlying such processes, and might also
prove to be a convenient platform to test drugs involved in
reversing glycation-associated pathology.
5. Materials and methods
5.1. Materials
Chemicals used in solid phase synthetic procedures were ob-
tained from Novabiochem (Nottingham, UK), Bachem (Buben-
dorf, Switzerland) or Sigma (St. Louis, MO, USA). Tri£uoroace-
tic acid (TFA) and piperidine were purchased from Chem-Impex
International Inc. (Wood Dale, IL, USA). The resin (PAL-PEG-
PS) used in peptide synthesis was purchased from PerSeptive
Biosystems (Hertford, UK). All other chemicals used were from
local manufacturers like Ranbaxy and E. Merck India.
5.2. Peptide synthesis
The target peptides were synthesized on a LKB-Biolynx 4175
semi-automatic peptide synthesiser using standard Fmoc (9-£uo-
renylmethyloxycarbonyl) chemistry and puri¢ed by reverse-phase
high performance liquid chromatography (HPLC). The peptides
were acetylated at the N-terminus prior to cleavage using 1:1
acetic acid/acetic anhydride. The peptides were cleaved as peptide
amides from the PAL-resin using 94% (v/v) TFA, 5% (v/v) anisole
and 1% (v/v) ethanedithiol. The pure peptides were characterized
by ESI-MS and used in all subsequent experiments (Table 1).
Concentrations of stock solutions were determined by tyrosine
absorbance (O275V1420 M31cm31)
5.3. Circular dichroism measurements
Circular dichroism spectra were recorded on a JASCO J-715
CD spectropolarimeter. Spectra were recorded between 250 and
195 nm at 0.1 nm intervals with a time constant of 4 s at room
temperature. Spectral data were averaged over four separate
scans. A rectangular cell of path length 0.1 cm was used for
the spectral range with peptide concentration approximately 50
WM. Peptide stock solutions were made in methanol and diluted
into methanol or water/methanol mixtures (50% v/v) to the re-
quired concentration.
5.4. MS
All electrospray spectra were recorded in the positive ion de-
tection mode on a Hewlett Packard 1100 MSD model electro-
spray mass spectrometer equipped with a single quadrupole and a
conventional electrospray source. Pure water from a Milli Q ap-
paratus (Millipore Inc.) with a conductance of 18.2 m6 was
mixed with equal volume of methanol and used as the running
solvent. The solvent £ow rate was 30 Wl min31. Approximately
200^300 pmol of sample were injected each time for analysis. The
source temperature was kept at 300‡C. Ions were extracted with
an ori¢ce potential of 4000 V applied at the nebulizer tip. The
ionization was pneumatically assisted using a constant £ow of
pure N2 gas at 10 l min31 using a Whatman Nitrogen generator.
The same gas was used to maintain the nebulizer pressure at
10 bar. The nozzle skimmer potential was kept at 20 V. The
mass spectrometer was calibrated using standards supplied by
the manufacturer that yield ¢ve m/z ions across the mass range
m/z 118^2500. The ion chromatographic peak width for operation
was 0.18 min. The cycle time was 1.90 s/cycle and the time ¢lter
was kept on. Data were acquired in the scan mode for 2 min and
averaged over the complete ion chromatogram to obtain the mass
spectrum. The charge states were determined using the isotopic
distribution of the peaks and from the di¡erence between the
peak values of the protonated species and sodium adducts.
5.5. Reaction of glucose with peptides
Peptide (1 mM in methanol) was mixed with an equal volume
of D-glucose (1 M in water) to give a ¢nal peptide: glucose ratio
of 1:1000 in a 50% (v/v) water/methanol solution. Reaction mix-
tures were adjusted to a pH of 8.5 using sodium bicarbonate
bu¡er (¢nal concentration 12.5 mM) and incubated at 37‡C. Ali-
quots were removed periodically, diluted 10-fold and analyzed by
MS.
5.6. Di¡erentiation between aldimine and ketoamine products
Aliquots of the reaction mixture were periodically diluted 10-
fold into a 5 mM solution of hydroxylamine in water (¢nal pep-
tide: hydroxylamine ratio 1:100), incubated for 15 min and ana-
lyzed by MS. The commercially available hydrochloride salt of
hydroxylamine was neutralized using sodium bicarbonate prior to
use (¢nal pHV6.0).
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